Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Other Non Operating Income (2019 - 2025)

Burning Rock Biotech has reported Other Non Operating Income over the past 7 years, most recently at -$566000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 194.97% year-over-year to -$566000.0; the TTM value through Dec 2025 reached -$601000.0, down 195.85%, while the annual FY2025 figure was -$960000.0, 6757.14% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$566000.0 at Burning Rock Biotech, down from $1000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $596000.0 in Q4 2024 and troughed at -$566000.0 in Q4 2025.
  • A 5-year average of $7750.0 and a median of $2000.0 in 2021 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: tumbled 1000.0% in 2022 and later surged 2491.3% in 2024.
  • Year by year, Other Non Operating Income stood at -$58000.0 in 2021, then soared by 79.31% to -$12000.0 in 2022, then skyrocketed by 291.67% to $23000.0 in 2023, then surged by 2491.3% to $596000.0 in 2024, then plummeted by 194.97% to -$566000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for BNR at -$566000.0 in Q4 2025, $1000.0 in Q3 2025, and $54000.0 in Q2 2025.